Ladiratuzumab vedotin

製品コード：D4057         Batch: D405701

印刷

Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.

製品説明

Formulation 1xPBS
DAR 4.16
ADC antiody ladiratuzumab
ADC linker A proteolytically cleavable type linker
ADC cytotoxin MMAE
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99.15%
Protein concentration 3.21mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。